Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Set to Close Acquisition of Packard BioScience on Nov. 13

NEW YORK, Nov. 12 – The Federal Trade Commission has approved PerkinElmer's proposed acquisition of Packard BioScience and the deal is now set to close on November 13, PerkinElmer said Monday.

"We will now move quickly to integrate these highly complementary businesses into the world's premier provider of drug discovery solutions," Grergory Summe, CEO of PerkinElmer, said in a statement.

Summe said that Packard BioScience’s automated liquid handling, sample preparation tools, and advanced biochip technologies would add to PerkinElmer’s arsenal of genomics and proteomics technologies.

"Packard BioScience's core capabilities in this area, its complementary range of products, its impressive new product development pipeline, and its well-respected team of field sales and service experts will enable us to provide more powerful solutions to our expanding base of life sciences customers," Summe said.

In July PerkinElmer announced that it had agreed to acquire Packard BioScience in a stock deal valued at about $650 million.

Summe told an investor meeting last month that the acquisition of Meriden, Conn.-based Packard BioScience should help PerkinElmer increase to $2.5 billion its total revenues in 2004, and push its earnings-per-share rate to roughly 19 percent in the same year.

Packard BioScience has approximately 1,000 employees and sales in 60 countries in North America, Europe and Asia. The company expects revenues of approximately $200 million in 2001.

Boston-based PerkinElmer is currently the third-largest life sciences company in the US.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.